nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA6—ear—melanoma	0.0153	0.0919	CbGeAlD
Topiramate—GRIA4—eye—melanoma	0.00926	0.0555	CbGeAlD
Topiramate—GRIA4—retina—melanoma	0.00918	0.055	CbGeAlD
Topiramate—GRIK3—retina—melanoma	0.00847	0.0508	CbGeAlD
Topiramate—GRIK1—eye—melanoma	0.00812	0.0487	CbGeAlD
Topiramate—CA6—hair follicle—melanoma	0.00807	0.0484	CbGeAlD
Topiramate—GRIK1—retina—melanoma	0.00805	0.0483	CbGeAlD
Topiramate—GRIK3—mammalian vulva—melanoma	0.00678	0.0407	CbGeAlD
Topiramate—GRIK4—head—melanoma	0.00665	0.0399	CbGeAlD
Topiramate—GRIA4—head—melanoma	0.00526	0.0315	CbGeAlD
Topiramate—GRIK3—head—melanoma	0.00485	0.0291	CbGeAlD
Topiramate—GRIK5—head—melanoma	0.00485	0.0291	CbGeAlD
Topiramate—GRIK1—head—melanoma	0.00461	0.0276	CbGeAlD
Topiramate—GRIA3—head—melanoma	0.00428	0.0257	CbGeAlD
Topiramate—GRIA1—eye—melanoma	0.00403	0.0242	CbGeAlD
Topiramate—GRIA1—retina—melanoma	0.00399	0.024	CbGeAlD
Topiramate—GRIK3—lymph node—melanoma	0.0034	0.0204	CbGeAlD
Topiramate—GRIK5—lymph node—melanoma	0.0034	0.0204	CbGeAlD
Topiramate—GRIK2—eye—melanoma	0.00289	0.0174	CbGeAlD
Topiramate—GRIK2—retina—melanoma	0.00287	0.0172	CbGeAlD
Topiramate—CA2—hair follicle—melanoma	0.00278	0.0167	CbGeAlD
Topiramate—CA12—eye—melanoma	0.0027	0.0162	CbGeAlD
Topiramate—CA6—head—melanoma	0.00229	0.0137	CbGeAlD
Topiramate—GRIA1—head—melanoma	0.00229	0.0137	CbGeAlD
Topiramate—CA4—neck—melanoma	0.00225	0.0135	CbGeAlD
Topiramate—CA1—eye—melanoma	0.00214	0.0128	CbGeAlD
Topiramate—CA5B—mammalian vulva—melanoma	0.00192	0.0115	CbGeAlD
Topiramate—CA2—neck—melanoma	0.00187	0.0112	CbGeAlD
Topiramate—GRIA2—head—melanoma	0.00182	0.0109	CbGeAlD
Topiramate—SCN1A—head—melanoma	0.00166	0.00995	CbGeAlD
Topiramate—GRIK2—head—melanoma	0.00164	0.00985	CbGeAlD
Topiramate—CA12—head—melanoma	0.00153	0.0092	CbGeAlD
Topiramate—CA2—eye—melanoma	0.00139	0.00832	CbGeAlD
Topiramate—CA5B—head—melanoma	0.00138	0.00826	CbGeAlD
Topiramate—CA2—retina—melanoma	0.00138	0.00825	CbGeAlD
Topiramate—SCN5A—head—melanoma	0.00133	0.008	CbGeAlD
Topiramate—GABRB2—head—melanoma	0.00129	0.00776	CbGeAlD
Topiramate—GABRG2—head—melanoma	0.00129	0.00776	CbGeAlD
Topiramate—CA1—head—melanoma	0.00122	0.00729	CbGeAlD
Topiramate—CA2—skin of body—melanoma	0.00121	0.00724	CbGeAlD
Topiramate—GABRA1—head—melanoma	0.00114	0.00685	CbGeAlD
Topiramate—CA2—mammalian vulva—melanoma	0.0011	0.00661	CbGeAlD
Topiramate—CA5B—lymph node—melanoma	0.000964	0.00578	CbGeAlD
Topiramate—CA4—head—melanoma	0.00095	0.0057	CbGeAlD
Topiramate—CA1—lymph node—melanoma	0.000851	0.00511	CbGeAlD
Topiramate—CA2—head—melanoma	0.000788	0.00473	CbGeAlD
Topiramate—CA4—lymph node—melanoma	0.000665	0.00399	CbGeAlD
Topiramate—CA2—lymph node—melanoma	0.000552	0.00331	CbGeAlD
Topiramate—Dehydration—Docetaxel—melanoma	0.000496	0.00104	CcSEcCtD
Topiramate—Ill-defined disorder—Dactinomycin—melanoma	0.000496	0.00104	CcSEcCtD
Topiramate—Anaemia—Dactinomycin—melanoma	0.000494	0.00103	CcSEcCtD
Topiramate—Liver function test abnormal—Docetaxel—melanoma	0.000493	0.00103	CcSEcCtD
Topiramate—Vomiting—Vemurafenib—melanoma	0.000491	0.00103	CcSEcCtD
Topiramate—Alopecia—Temozolomide—melanoma	0.00049	0.00103	CcSEcCtD
Topiramate—Chest pain—Bleomycin—melanoma	0.000488	0.00102	CcSEcCtD
Topiramate—Myalgia—Bleomycin—melanoma	0.000488	0.00102	CcSEcCtD
Topiramate—Orthostatic hypotension—Docetaxel—melanoma	0.000487	0.00102	CcSEcCtD
Topiramate—Abdominal pain upper—Docetaxel—melanoma	0.000487	0.00102	CcSEcCtD
Topiramate—Rash—Vemurafenib—melanoma	0.000486	0.00102	CcSEcCtD
Topiramate—Mental disorder—Temozolomide—melanoma	0.000486	0.00102	CcSEcCtD
Topiramate—Dermatitis—Vemurafenib—melanoma	0.000486	0.00102	CcSEcCtD
Topiramate—Back pain—Carmustine—melanoma	0.000484	0.00101	CcSEcCtD
Topiramate—Headache—Vemurafenib—melanoma	0.000483	0.00101	CcSEcCtD
Topiramate—Erythema—Temozolomide—melanoma	0.000483	0.00101	CcSEcCtD
Topiramate—Malnutrition—Temozolomide—melanoma	0.000483	0.00101	CcSEcCtD
Topiramate—Breast disorder—Docetaxel—melanoma	0.000482	0.00101	CcSEcCtD
Topiramate—Discomfort—Bleomycin—melanoma	0.000482	0.00101	CcSEcCtD
Topiramate—Malaise—Dactinomycin—melanoma	0.000482	0.00101	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00048	0.001	CcSEcCtD
Topiramate—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00048	0.001	CcSEcCtD
Topiramate—Leukopenia—Dactinomycin—melanoma	0.000478	0.001	CcSEcCtD
Topiramate—Nasopharyngitis—Docetaxel—melanoma	0.000477	0.000998	CcSEcCtD
Topiramate—Dysgeusia—Temozolomide—melanoma	0.000473	0.00099	CcSEcCtD
Topiramate—Confusional state—Bleomycin—melanoma	0.000471	0.000986	CcSEcCtD
Topiramate—Vision blurred—Carmustine—melanoma	0.000471	0.000986	CcSEcCtD
Topiramate—Alanine aminotransferase increased—Docetaxel—melanoma	0.000471	0.000984	CcSEcCtD
Topiramate—Tremor—Carmustine—melanoma	0.000468	0.00098	CcSEcCtD
Topiramate—Oedema—Bleomycin—melanoma	0.000467	0.000978	CcSEcCtD
Topiramate—Back pain—Temozolomide—melanoma	0.000467	0.000978	CcSEcCtD
Topiramate—Infection—Bleomycin—melanoma	0.000464	0.000971	CcSEcCtD
Topiramate—Anaemia—Carmustine—melanoma	0.000462	0.000967	CcSEcCtD
Topiramate—Dysphagia—Docetaxel—melanoma	0.000461	0.000965	CcSEcCtD
Topiramate—Agitation—Carmustine—melanoma	0.000459	0.000961	CcSEcCtD
Topiramate—Nausea—Vemurafenib—melanoma	0.000458	0.000959	CcSEcCtD
Topiramate—Thrombocytopenia—Bleomycin—melanoma	0.000458	0.000957	CcSEcCtD
Topiramate—Vision blurred—Temozolomide—melanoma	0.000455	0.000952	CcSEcCtD
Topiramate—Myalgia—Dactinomycin—melanoma	0.000455	0.000951	CcSEcCtD
Topiramate—Tremor—Temozolomide—melanoma	0.000453	0.000947	CcSEcCtD
Topiramate—Discomfort—Dactinomycin—melanoma	0.000449	0.00094	CcSEcCtD
Topiramate—Angina pectoris—Docetaxel—melanoma	0.000449	0.00094	CcSEcCtD
Topiramate—Ill-defined disorder—Temozolomide—melanoma	0.000448	0.000938	CcSEcCtD
Topiramate—Leukopenia—Carmustine—melanoma	0.000448	0.000936	CcSEcCtD
Topiramate—Anaemia—Temozolomide—melanoma	0.000447	0.000934	CcSEcCtD
Topiramate—Anorexia—Bleomycin—melanoma	0.000446	0.000932	CcSEcCtD
Topiramate—Agitation—Temozolomide—melanoma	0.000444	0.000929	CcSEcCtD
Topiramate—Pancytopenia—Docetaxel—melanoma	0.000438	0.000916	CcSEcCtD
Topiramate—Hypotension—Bleomycin—melanoma	0.000437	0.000914	CcSEcCtD
Topiramate—Oedema—Dactinomycin—melanoma	0.000436	0.000912	CcSEcCtD
Topiramate—Malaise—Temozolomide—melanoma	0.000436	0.000911	CcSEcCtD
Topiramate—Vertigo—Temozolomide—melanoma	0.000434	0.000908	CcSEcCtD
Topiramate—Convulsion—Carmustine—melanoma	0.000433	0.000906	CcSEcCtD
Topiramate—Infection—Dactinomycin—melanoma	0.000433	0.000906	CcSEcCtD
Topiramate—Leukopenia—Temozolomide—melanoma	0.000432	0.000905	CcSEcCtD
Topiramate—Hypertension—Carmustine—melanoma	0.000432	0.000903	CcSEcCtD
Topiramate—Neutropenia—Docetaxel—melanoma	0.000431	0.000902	CcSEcCtD
Topiramate—Palpitations—Temozolomide—melanoma	0.000427	0.000893	CcSEcCtD
Topiramate—Thrombocytopenia—Dactinomycin—melanoma	0.000427	0.000893	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000426	0.000891	CcSEcCtD
Topiramate—Chest pain—Carmustine—melanoma	0.000426	0.00089	CcSEcCtD
Topiramate—Myalgia—Carmustine—melanoma	0.000426	0.00089	CcSEcCtD
Topiramate—Anxiety—Carmustine—melanoma	0.000424	0.000887	CcSEcCtD
Topiramate—Cough—Temozolomide—melanoma	0.000422	0.000882	CcSEcCtD
Topiramate—Paraesthesia—Bleomycin—melanoma	0.00042	0.000878	CcSEcCtD
Topiramate—Weight increased—Docetaxel—melanoma	0.00042	0.000878	CcSEcCtD
Topiramate—Convulsion—Temozolomide—melanoma	0.000419	0.000876	CcSEcCtD
Topiramate—Weight decreased—Docetaxel—melanoma	0.000417	0.000873	CcSEcCtD
Topiramate—Hypertension—Temozolomide—melanoma	0.000417	0.000873	CcSEcCtD
Topiramate—Dyspnoea—Bleomycin—melanoma	0.000417	0.000872	CcSEcCtD
Topiramate—Anorexia—Dactinomycin—melanoma	0.000416	0.000869	CcSEcCtD
Topiramate—Pneumonia—Docetaxel—melanoma	0.000414	0.000865	CcSEcCtD
Topiramate—Confusional state—Carmustine—melanoma	0.000411	0.000861	CcSEcCtD
Topiramate—Myalgia—Temozolomide—melanoma	0.000411	0.00086	CcSEcCtD
Topiramate—Arthralgia—Temozolomide—melanoma	0.000411	0.00086	CcSEcCtD
Topiramate—Infestation NOS—Docetaxel—melanoma	0.000411	0.00086	CcSEcCtD
Topiramate—Infestation—Docetaxel—melanoma	0.000411	0.00086	CcSEcCtD
Topiramate—Anxiety—Temozolomide—melanoma	0.00041	0.000857	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000409	0.000854	CcSEcCtD
Topiramate—Oedema—Carmustine—melanoma	0.000408	0.000853	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000408	0.000853	CcSEcCtD
Topiramate—Discomfort—Temozolomide—melanoma	0.000406	0.00085	CcSEcCtD
Topiramate—Decreased appetite—Bleomycin—melanoma	0.000406	0.00085	CcSEcCtD
Topiramate—Infection—Carmustine—melanoma	0.000405	0.000848	CcSEcCtD
Topiramate—Renal failure—Docetaxel—melanoma	0.000404	0.000845	CcSEcCtD
Topiramate—Neuropathy peripheral—Docetaxel—melanoma	0.000403	0.000843	CcSEcCtD
Topiramate—Dry mouth—Temozolomide—melanoma	0.000402	0.000841	CcSEcCtD
Topiramate—Stomatitis—Docetaxel—melanoma	0.000401	0.000838	CcSEcCtD
Topiramate—Pain—Bleomycin—melanoma	0.0004	0.000836	CcSEcCtD
Topiramate—Conjunctivitis—Docetaxel—melanoma	0.0004	0.000836	CcSEcCtD
Topiramate—Thrombocytopenia—Carmustine—melanoma	0.0004	0.000836	CcSEcCtD
Topiramate—Tachycardia—Carmustine—melanoma	0.000398	0.000833	CcSEcCtD
Topiramate—Confusional state—Temozolomide—melanoma	0.000398	0.000832	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000397	0.000831	CcSEcCtD
Topiramate—Oedema—Temozolomide—melanoma	0.000394	0.000825	CcSEcCtD
Topiramate—Infection—Temozolomide—melanoma	0.000392	0.000819	CcSEcCtD
Topiramate—Anorexia—Carmustine—melanoma	0.000389	0.000814	CcSEcCtD
Topiramate—Epistaxis—Docetaxel—melanoma	0.000388	0.000811	CcSEcCtD
Topiramate—Nervous system disorder—Temozolomide—melanoma	0.000387	0.000809	CcSEcCtD
Topiramate—Thrombocytopenia—Temozolomide—melanoma	0.000386	0.000808	CcSEcCtD
Topiramate—Feeling abnormal—Bleomycin—melanoma	0.000385	0.000806	CcSEcCtD
Topiramate—Agranulocytosis—Docetaxel—melanoma	0.000384	0.000803	CcSEcCtD
Topiramate—Skin disorder—Temozolomide—melanoma	0.000383	0.000801	CcSEcCtD
Topiramate—Hypotension—Carmustine—melanoma	0.000381	0.000798	CcSEcCtD
Topiramate—Hyperhidrosis—Temozolomide—melanoma	0.000381	0.000797	CcSEcCtD
Topiramate—Decreased appetite—Dactinomycin—melanoma	0.000379	0.000793	CcSEcCtD
Topiramate—Fatigue—Dactinomycin—melanoma	0.000376	0.000786	CcSEcCtD
Topiramate—Anorexia—Temozolomide—melanoma	0.000376	0.000786	CcSEcCtD
Topiramate—Pain—Dactinomycin—melanoma	0.000373	0.00078	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Carmustine—melanoma	0.000372	0.000778	CcSEcCtD
Topiramate—Urticaria—Bleomycin—melanoma	0.000371	0.000777	CcSEcCtD
Topiramate—Haemoglobin—Docetaxel—melanoma	0.000371	0.000776	CcSEcCtD
Topiramate—Rhinitis—Docetaxel—melanoma	0.00037	0.000774	CcSEcCtD
Topiramate—Body temperature increased—Bleomycin—melanoma	0.00037	0.000773	CcSEcCtD
Topiramate—Haemorrhage—Docetaxel—melanoma	0.000369	0.000772	CcSEcCtD
Topiramate—Hepatitis—Docetaxel—melanoma	0.000369	0.000772	CcSEcCtD
Topiramate—Insomnia—Carmustine—melanoma	0.000369	0.000772	CcSEcCtD
Topiramate—Hypoaesthesia—Docetaxel—melanoma	0.000367	0.000768	CcSEcCtD
Topiramate—Paraesthesia—Carmustine—melanoma	0.000366	0.000766	CcSEcCtD
Topiramate—Pharyngitis—Docetaxel—melanoma	0.000366	0.000766	CcSEcCtD
Topiramate—Urinary tract disorder—Docetaxel—melanoma	0.000365	0.000762	CcSEcCtD
Topiramate—Dyspnoea—Carmustine—melanoma	0.000364	0.000761	CcSEcCtD
Topiramate—Oedema peripheral—Docetaxel—melanoma	0.000364	0.000761	CcSEcCtD
Topiramate—Somnolence—Carmustine—melanoma	0.000363	0.000759	CcSEcCtD
Topiramate—Connective tissue disorder—Docetaxel—melanoma	0.000363	0.000759	CcSEcCtD
Topiramate—Urethral disorder—Docetaxel—melanoma	0.000362	0.000757	CcSEcCtD
Topiramate—Feeling abnormal—Dactinomycin—melanoma	0.000359	0.000751	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000359	0.000751	CcSEcCtD
Topiramate—Insomnia—Temozolomide—melanoma	0.000357	0.000746	CcSEcCtD
Topiramate—Gastrointestinal pain—Dactinomycin—melanoma	0.000357	0.000746	CcSEcCtD
Topiramate—Visual impairment—Docetaxel—melanoma	0.000356	0.000744	CcSEcCtD
Topiramate—Decreased appetite—Carmustine—melanoma	0.000355	0.000742	CcSEcCtD
Topiramate—Paraesthesia—Temozolomide—melanoma	0.000354	0.000741	CcSEcCtD
Topiramate—Gastrointestinal disorder—Carmustine—melanoma	0.000352	0.000737	CcSEcCtD
Topiramate—Dyspnoea—Temozolomide—melanoma	0.000352	0.000735	CcSEcCtD
Topiramate—Somnolence—Temozolomide—melanoma	0.000351	0.000733	CcSEcCtD
Topiramate—Erythema multiforme—Docetaxel—melanoma	0.000349	0.00073	CcSEcCtD
Topiramate—Constipation—Carmustine—melanoma	0.000349	0.00073	CcSEcCtD
Topiramate—Pain—Carmustine—melanoma	0.000349	0.00073	CcSEcCtD
Topiramate—Dyspepsia—Temozolomide—melanoma	0.000347	0.000726	CcSEcCtD
Topiramate—Eye disorder—Docetaxel—melanoma	0.000345	0.000721	CcSEcCtD
Topiramate—Body temperature increased—Dactinomycin—melanoma	0.000345	0.000721	CcSEcCtD
Topiramate—Abdominal pain—Dactinomycin—melanoma	0.000345	0.000721	CcSEcCtD
Topiramate—Hypersensitivity—Bleomycin—melanoma	0.000344	0.00072	CcSEcCtD
Topiramate—Decreased appetite—Temozolomide—melanoma	0.000343	0.000717	CcSEcCtD
Topiramate—Flushing—Docetaxel—melanoma	0.000343	0.000717	CcSEcCtD
Topiramate—Cardiac disorder—Docetaxel—melanoma	0.000343	0.000717	CcSEcCtD
Topiramate—Gastrointestinal disorder—Temozolomide—melanoma	0.00034	0.000712	CcSEcCtD
Topiramate—Fatigue—Temozolomide—melanoma	0.00034	0.000711	CcSEcCtD
Topiramate—Constipation—Temozolomide—melanoma	0.000337	0.000705	CcSEcCtD
Topiramate—Pain—Temozolomide—melanoma	0.000337	0.000705	CcSEcCtD
Topiramate—Feeling abnormal—Carmustine—melanoma	0.000336	0.000703	CcSEcCtD
Topiramate—Asthenia—Bleomycin—melanoma	0.000335	0.000702	CcSEcCtD
Topiramate—Angiopathy—Docetaxel—melanoma	0.000335	0.0007	CcSEcCtD
Topiramate—Gastrointestinal pain—Carmustine—melanoma	0.000334	0.000698	CcSEcCtD
Topiramate—Immune system disorder—Docetaxel—melanoma	0.000333	0.000697	CcSEcCtD
Topiramate—Mediastinal disorder—Docetaxel—melanoma	0.000333	0.000696	CcSEcCtD
Topiramate—Chills—Docetaxel—melanoma	0.000331	0.000693	CcSEcCtD
Topiramate—Pruritus—Bleomycin—melanoma	0.000331	0.000692	CcSEcCtD
Topiramate—Alopecia—Docetaxel—melanoma	0.000326	0.000682	CcSEcCtD
Topiramate—Feeling abnormal—Temozolomide—melanoma	0.000325	0.00068	CcSEcCtD
Topiramate—Mental disorder—Docetaxel—melanoma	0.000323	0.000676	CcSEcCtD
Topiramate—Abdominal pain—Carmustine—melanoma	0.000323	0.000675	CcSEcCtD
Topiramate—Body temperature increased—Carmustine—melanoma	0.000323	0.000675	CcSEcCtD
Topiramate—Gastrointestinal pain—Temozolomide—melanoma	0.000322	0.000674	CcSEcCtD
Topiramate—Erythema—Docetaxel—melanoma	0.000321	0.000672	CcSEcCtD
Topiramate—Malnutrition—Docetaxel—melanoma	0.000321	0.000672	CcSEcCtD
Topiramate—Hypersensitivity—Dactinomycin—melanoma	0.000321	0.000672	CcSEcCtD
Topiramate—Dysgeusia—Docetaxel—melanoma	0.000315	0.000658	CcSEcCtD
Topiramate—Urticaria—Temozolomide—melanoma	0.000313	0.000655	CcSEcCtD
Topiramate—Asthenia—Dactinomycin—melanoma	0.000313	0.000654	CcSEcCtD
Topiramate—Abdominal pain—Temozolomide—melanoma	0.000312	0.000652	CcSEcCtD
Topiramate—Body temperature increased—Temozolomide—melanoma	0.000312	0.000652	CcSEcCtD
Topiramate—Back pain—Docetaxel—melanoma	0.000311	0.00065	CcSEcCtD
Topiramate—Muscle spasms—Docetaxel—melanoma	0.000309	0.000646	CcSEcCtD
Topiramate—Hypersensitivity—Carmustine—melanoma	0.000301	0.000629	CcSEcCtD
Topiramate—Diarrhoea—Dactinomycin—melanoma	0.000298	0.000624	CcSEcCtD
Topiramate—Vomiting—Bleomycin—melanoma	0.000297	0.000622	CcSEcCtD
Topiramate—Anaemia—Docetaxel—melanoma	0.000297	0.000621	CcSEcCtD
Topiramate—Rash—Bleomycin—melanoma	0.000295	0.000617	CcSEcCtD
Topiramate—Dermatitis—Bleomycin—melanoma	0.000294	0.000616	CcSEcCtD
Topiramate—Asthenia—Carmustine—melanoma	0.000293	0.000612	CcSEcCtD
Topiramate—Hypersensitivity—Temozolomide—melanoma	0.000291	0.000608	CcSEcCtD
Topiramate—Syncope—Docetaxel—melanoma	0.000288	0.000603	CcSEcCtD
Topiramate—Leukopenia—Docetaxel—melanoma	0.000288	0.000602	CcSEcCtD
Topiramate—Palpitations—Docetaxel—melanoma	0.000284	0.000594	CcSEcCtD
Topiramate—Asthenia—Temozolomide—melanoma	0.000283	0.000592	CcSEcCtD
Topiramate—Loss of consciousness—Docetaxel—melanoma	0.000282	0.000591	CcSEcCtD
Topiramate—Cough—Docetaxel—melanoma	0.00028	0.000586	CcSEcCtD
Topiramate—Diarrhoea—Carmustine—melanoma	0.000279	0.000584	CcSEcCtD
Topiramate—Pruritus—Temozolomide—melanoma	0.000279	0.000584	CcSEcCtD
Topiramate—Convulsion—Docetaxel—melanoma	0.000278	0.000582	CcSEcCtD
Topiramate—Nausea—Bleomycin—melanoma	0.000278	0.000581	CcSEcCtD
Topiramate—Hypertension—Docetaxel—melanoma	0.000277	0.00058	CcSEcCtD
Topiramate—Vomiting—Dactinomycin—melanoma	0.000277	0.00058	CcSEcCtD
Topiramate—Rash—Dactinomycin—melanoma	0.000275	0.000575	CcSEcCtD
Topiramate—Myalgia—Docetaxel—melanoma	0.000274	0.000572	CcSEcCtD
Topiramate—Arthralgia—Docetaxel—melanoma	0.000274	0.000572	CcSEcCtD
Topiramate—Chest pain—Docetaxel—melanoma	0.000274	0.000572	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000272	0.000568	CcSEcCtD
Topiramate—Dizziness—Carmustine—melanoma	0.00027	0.000564	CcSEcCtD
Topiramate—Diarrhoea—Temozolomide—melanoma	0.00027	0.000564	CcSEcCtD
Topiramate—Dry mouth—Docetaxel—melanoma	0.000268	0.00056	CcSEcCtD
Topiramate—Confusional state—Docetaxel—melanoma	0.000264	0.000553	CcSEcCtD
Topiramate—Oedema—Docetaxel—melanoma	0.000262	0.000549	CcSEcCtD
Topiramate—Dizziness—Temozolomide—melanoma	0.000261	0.000545	CcSEcCtD
Topiramate—Infection—Docetaxel—melanoma	0.000261	0.000545	CcSEcCtD
Topiramate—Vomiting—Carmustine—melanoma	0.000259	0.000543	CcSEcCtD
Topiramate—Nausea—Dactinomycin—melanoma	0.000259	0.000542	CcSEcCtD
Topiramate—Shock—Docetaxel—melanoma	0.000258	0.00054	CcSEcCtD
Topiramate—Rash—Carmustine—melanoma	0.000257	0.000538	CcSEcCtD
Topiramate—Nervous system disorder—Docetaxel—melanoma	0.000257	0.000538	CcSEcCtD
Topiramate—Dermatitis—Carmustine—melanoma	0.000257	0.000538	CcSEcCtD
Topiramate—Thrombocytopenia—Docetaxel—melanoma	0.000257	0.000537	CcSEcCtD
Topiramate—Tachycardia—Docetaxel—melanoma	0.000256	0.000535	CcSEcCtD
Topiramate—Headache—Carmustine—melanoma	0.000256	0.000535	CcSEcCtD
Topiramate—Skin disorder—Docetaxel—melanoma	0.000255	0.000533	CcSEcCtD
Topiramate—Vomiting—Temozolomide—melanoma	0.000251	0.000524	CcSEcCtD
Topiramate—Anorexia—Docetaxel—melanoma	0.00025	0.000523	CcSEcCtD
Topiramate—Rash—Temozolomide—melanoma	0.000249	0.00052	CcSEcCtD
Topiramate—Dermatitis—Temozolomide—melanoma	0.000248	0.00052	CcSEcCtD
Topiramate—Headache—Temozolomide—melanoma	0.000247	0.000517	CcSEcCtD
Topiramate—Hypotension—Docetaxel—melanoma	0.000245	0.000513	CcSEcCtD
Topiramate—Nausea—Carmustine—melanoma	0.000242	0.000507	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000239	0.0005	CcSEcCtD
Topiramate—Insomnia—Docetaxel—melanoma	0.000237	0.000496	CcSEcCtD
Topiramate—Paraesthesia—Docetaxel—melanoma	0.000235	0.000493	CcSEcCtD
Topiramate—Nausea—Temozolomide—melanoma	0.000234	0.00049	CcSEcCtD
Topiramate—Dyspnoea—Docetaxel—melanoma	0.000234	0.000489	CcSEcCtD
Topiramate—Somnolence—Docetaxel—melanoma	0.000233	0.000488	CcSEcCtD
Topiramate—Dyspepsia—Docetaxel—melanoma	0.000231	0.000483	CcSEcCtD
Topiramate—Decreased appetite—Docetaxel—melanoma	0.000228	0.000477	CcSEcCtD
Topiramate—Gastrointestinal disorder—Docetaxel—melanoma	0.000226	0.000474	CcSEcCtD
Topiramate—Fatigue—Docetaxel—melanoma	0.000226	0.000473	CcSEcCtD
Topiramate—Constipation—Docetaxel—melanoma	0.000224	0.000469	CcSEcCtD
Topiramate—Pain—Docetaxel—melanoma	0.000224	0.000469	CcSEcCtD
Topiramate—Feeling abnormal—Docetaxel—melanoma	0.000216	0.000452	CcSEcCtD
Topiramate—Gastrointestinal pain—Docetaxel—melanoma	0.000214	0.000449	CcSEcCtD
Topiramate—Body temperature increased—Docetaxel—melanoma	0.000207	0.000434	CcSEcCtD
Topiramate—Abdominal pain—Docetaxel—melanoma	0.000207	0.000434	CcSEcCtD
Topiramate—Hypersensitivity—Docetaxel—melanoma	0.000193	0.000404	CcSEcCtD
Topiramate—Asthenia—Docetaxel—melanoma	0.000188	0.000394	CcSEcCtD
Topiramate—Pruritus—Docetaxel—melanoma	0.000186	0.000388	CcSEcCtD
Topiramate—Diarrhoea—Docetaxel—melanoma	0.000179	0.000375	CcSEcCtD
Topiramate—Dizziness—Docetaxel—melanoma	0.000173	0.000363	CcSEcCtD
Topiramate—Vomiting—Docetaxel—melanoma	0.000167	0.000349	CcSEcCtD
Topiramate—Rash—Docetaxel—melanoma	0.000165	0.000346	CcSEcCtD
Topiramate—Dermatitis—Docetaxel—melanoma	0.000165	0.000346	CcSEcCtD
Topiramate—Headache—Docetaxel—melanoma	0.000164	0.000344	CcSEcCtD
Topiramate—Nausea—Docetaxel—melanoma	0.000156	0.000326	CcSEcCtD
Topiramate—CA1—Metabolism—CYP1B1—melanoma	5.16e-05	0.000145	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—MAPK1—melanoma	5.12e-05	0.000144	CbGpPWpGaD
Topiramate—CA9—Metabolism—GNA11—melanoma	5.09e-05	0.000143	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—melanoma	5.05e-05	0.000142	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	5e-05	0.000141	CbGpPWpGaD
Topiramate—CA9—Metabolism—FASN—melanoma	4.98e-05	0.00014	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	4.97e-05	0.00014	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP2—melanoma	4.96e-05	0.00014	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAP2K1—melanoma	4.96e-05	0.00014	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ACER3—melanoma	4.95e-05	0.000139	CbGpPWpGaD
Topiramate—CA9—Metabolism—SLC5A5—melanoma	4.9e-05	0.000138	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CG—melanoma	4.83e-05	0.000136	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CG—melanoma	4.83e-05	0.000136	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—HRAS—melanoma	4.83e-05	0.000136	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—melanoma	4.77e-05	0.000134	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	4.76e-05	0.000134	CbGpPWpGaD
Topiramate—CA9—Metabolism—GNAQ—melanoma	4.73e-05	0.000133	CbGpPWpGaD
Topiramate—CA9—Metabolism—CD44—melanoma	4.73e-05	0.000133	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—STAT3—melanoma	4.72e-05	0.000133	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—FGF2—melanoma	4.71e-05	0.000133	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NRAS—melanoma	4.71e-05	0.000132	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—melanoma	4.69e-05	0.000132	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	4.69e-05	0.000132	CbGpPWpGaD
Topiramate—CA6—Metabolism—PPARG—melanoma	4.67e-05	0.000131	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PPARG—melanoma	4.67e-05	0.000131	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—NRAS—melanoma	4.64e-05	0.000131	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IL6—melanoma	4.63e-05	0.00013	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCB1—melanoma	4.63e-05	0.00013	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—IL6—melanoma	4.62e-05	0.00013	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MDM2—melanoma	4.59e-05	0.000129	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1B1—melanoma	4.54e-05	0.000128	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—UGT2B10—melanoma	4.53e-05	0.000128	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CG—melanoma	4.51e-05	0.000127	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CG—melanoma	4.51e-05	0.000127	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MAPK3—melanoma	4.51e-05	0.000127	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	4.47e-05	0.000126	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1B1—melanoma	4.47e-05	0.000126	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MAPK3—melanoma	4.44e-05	0.000125	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCB1—melanoma	4.44e-05	0.000125	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	4.41e-05	0.000124	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.37e-05	0.000123	CbGpPWpGaD
Topiramate—CA7—Metabolism—PPARG—melanoma	4.36e-05	0.000123	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PPARG—melanoma	4.36e-05	0.000123	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—ERBB2—melanoma	4.35e-05	0.000122	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	4.35e-05	0.000122	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MAPK1—melanoma	4.29e-05	0.000121	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—melanoma	4.29e-05	0.000121	CbGpPWpGaD
Topiramate—CA4—Metabolism—PRKCA—melanoma	4.26e-05	0.00012	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCB1—melanoma	4.25e-05	0.00012	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CD—melanoma	4.25e-05	0.00012	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CD—melanoma	4.25e-05	0.00012	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MAPK1—melanoma	4.23e-05	0.000119	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—melanoma	4.22e-05	0.000119	CbGpPWpGaD
Topiramate—CA4—Metabolism—ERCC2—melanoma	4.22e-05	0.000119	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HS3ST5—melanoma	4.21e-05	0.000119	CbGpPWpGaD
Topiramate—CA6—Metabolism—ALB—melanoma	4.2e-05	0.000118	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ALB—melanoma	4.2e-05	0.000118	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—HRAS—melanoma	4.2e-05	0.000118	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CG—melanoma	4.18e-05	0.000118	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—melanoma	4.11e-05	0.000116	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	4.1e-05	0.000115	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—melanoma	4.08e-05	0.000115	CbGpPWpGaD
Topiramate—CA2—Metabolism—PRKCA—melanoma	4.08e-05	0.000115	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—KRAS—melanoma	4.05e-05	0.000114	CbGpPWpGaD
Topiramate—CA2—Metabolism—ERCC2—melanoma	4.05e-05	0.000114	CbGpPWpGaD
Topiramate—CA12—Metabolism—PPARG—melanoma	4.04e-05	0.000114	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—KRAS—melanoma	3.99e-05	0.000112	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CD—melanoma	3.97e-05	0.000112	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CD—melanoma	3.97e-05	0.000112	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—MAPK1—melanoma	3.93e-05	0.00011	CbGpPWpGaD
Topiramate—CA7—Metabolism—ALB—melanoma	3.92e-05	0.00011	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ALB—melanoma	3.92e-05	0.00011	CbGpPWpGaD
Topiramate—CA1—Metabolism—PRKCA—melanoma	3.91e-05	0.00011	CbGpPWpGaD
Topiramate—CA1—Metabolism—ERCC2—melanoma	3.88e-05	0.000109	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	3.84e-05	0.000108	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CTNNB1—melanoma	3.81e-05	0.000107	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	3.76e-05	0.000106	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—melanoma	3.74e-05	0.000105	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—melanoma	3.73e-05	0.000105	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CB—melanoma	3.7e-05	0.000104	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CB—melanoma	3.7e-05	0.000104	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NFKB1—melanoma	3.69e-05	0.000104	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CD—melanoma	3.68e-05	0.000103	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—melanoma	3.67e-05	0.000103	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—melanoma	3.67e-05	0.000103	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALB—melanoma	3.63e-05	0.000102	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MAPK1—melanoma	3.59e-05	0.000101	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CB—melanoma	3.46e-05	9.74e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CB—melanoma	3.46e-05	9.74e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—melanoma	3.44e-05	9.69e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PRKCA—melanoma	3.44e-05	9.68e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—melanoma	3.43e-05	9.65e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—melanoma	3.43e-05	9.65e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ERCC2—melanoma	3.41e-05	9.6e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	3.4e-05	9.58e-05	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—HRAS—melanoma	3.39e-05	9.55e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.39e-05	9.54e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—melanoma	3.35e-05	9.43e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CG—melanoma	3.33e-05	9.39e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—melanoma	3.32e-05	9.34e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NRAS—melanoma	3.31e-05	9.31e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—melanoma	3.3e-05	9.28e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	3.29e-05	9.26e-05	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—melanoma	3.25e-05	9.14e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—melanoma	3.22e-05	9.06e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CB—melanoma	3.2e-05	9.02e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTEN—melanoma	3.2e-05	9.01e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTEN—melanoma	3.2e-05	9.01e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CG—melanoma	3.2e-05	9e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLCB4—melanoma	3.19e-05	8.99e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—melanoma	3.17e-05	8.94e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK3—melanoma	3.17e-05	8.92e-05	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—melanoma	3.15e-05	8.87e-05	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MAPK1—melanoma	3.14e-05	8.83e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	3.13e-05	8.82e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	3.11e-05	8.76e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—melanoma	3.09e-05	8.69e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CG—melanoma	3.07e-05	8.63e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—melanoma	3.04e-05	8.56e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK1—melanoma	3.02e-05	8.49e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—melanoma	3.01e-05	8.49e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIP4K2A—melanoma	3e-05	8.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC6A11—melanoma	3e-05	8.45e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTEN—melanoma	2.99e-05	8.41e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTEN—melanoma	2.99e-05	8.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ACER3—melanoma	2.98e-05	8.39e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—melanoma	2.96e-05	8.33e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CD—melanoma	2.93e-05	8.25e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTAP—melanoma	2.92e-05	8.22e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—melanoma	2.89e-05	8.15e-05	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—melanoma	2.88e-05	8.11e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—melanoma	2.87e-05	8.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.85e-05	8.03e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—melanoma	2.85e-05	8.02e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CD—melanoma	2.81e-05	7.91e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—melanoma	2.77e-05	7.81e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTEN—melanoma	2.77e-05	7.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UGT2B10—melanoma	2.72e-05	7.67e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	2.72e-05	7.66e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CG—melanoma	2.69e-05	7.59e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CD—melanoma	2.69e-05	7.59e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—melanoma	2.66e-05	7.49e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LUM—melanoma	2.6e-05	7.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PHGDH—melanoma	2.6e-05	7.33e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—melanoma	2.6e-05	7.32e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CB—melanoma	2.56e-05	7.19e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HPSE—melanoma	2.55e-05	7.18e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HS3ST5—melanoma	2.53e-05	7.13e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—melanoma	2.53e-05	7.13e-05	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—melanoma	2.52e-05	7.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CUBN—melanoma	2.5e-05	7.05e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CB—melanoma	2.45e-05	6.9e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—melanoma	2.43e-05	6.83e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—melanoma	2.42e-05	6.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BSG—melanoma	2.42e-05	6.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CSPG4—melanoma	2.42e-05	6.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SDHD—melanoma	2.42e-05	6.81e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CD—melanoma	2.37e-05	6.67e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CB—melanoma	2.35e-05	6.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPAM—melanoma	2.34e-05	6.6e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—melanoma	2.34e-05	6.58e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—melanoma	2.33e-05	6.55e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—melanoma	2.32e-05	6.52e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—melanoma	2.26e-05	6.36e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—melanoma	2.26e-05	6.36e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTEN—melanoma	2.21e-05	6.22e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—melanoma	2.14e-05	6.02e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTEN—melanoma	2.12e-05	5.96e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—melanoma	2.11e-05	5.94e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—melanoma	2.11e-05	5.94e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CB—melanoma	2.06e-05	5.81e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—melanoma	2.05e-05	5.76e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTEN—melanoma	2.03e-05	5.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLA2G6—melanoma	1.99e-05	5.61e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—melanoma	1.95e-05	5.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLCB4—melanoma	1.92e-05	5.4e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—melanoma	1.84e-05	5.19e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—melanoma	1.84e-05	5.19e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC6A11—melanoma	1.8e-05	5.08e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIP4K2A—melanoma	1.8e-05	5.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—VCAN—melanoma	1.79e-05	5.04e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTEN—melanoma	1.78e-05	5.02e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTAP—melanoma	1.76e-05	4.94e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—melanoma	1.72e-05	4.85e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—melanoma	1.72e-05	4.85e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.69e-05	4.77e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.63e-05	4.6e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—melanoma	1.6e-05	4.49e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LUM—melanoma	1.56e-05	4.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PHGDH—melanoma	1.56e-05	4.4e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—melanoma	1.56e-05	4.38e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HPSE—melanoma	1.53e-05	4.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP17A1—melanoma	1.51e-05	4.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CUBN—melanoma	1.51e-05	4.24e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—melanoma	1.49e-05	4.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.49e-05	4.19e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.47e-05	4.14e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SDHD—melanoma	1.45e-05	4.1e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BSG—melanoma	1.45e-05	4.1e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CSPG4—melanoma	1.45e-05	4.1e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—melanoma	1.43e-05	4.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNA11—melanoma	1.43e-05	4.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPAM—melanoma	1.41e-05	3.97e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FASN—melanoma	1.4e-05	3.93e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC5A5—melanoma	1.37e-05	3.86e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNAQ—melanoma	1.33e-05	3.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CD44—melanoma	1.33e-05	3.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.3e-05	3.65e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.29e-05	3.62e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—melanoma	1.27e-05	3.58e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1B1—melanoma	1.27e-05	3.58e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—melanoma	1.26e-05	3.54e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—melanoma	1.22e-05	3.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLA2G6—melanoma	1.2e-05	3.37e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—melanoma	1.17e-05	3.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.12e-05	3.16e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—VCAN—melanoma	1.08e-05	3.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—melanoma	1.05e-05	2.95e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—melanoma	1.03e-05	2.89e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PRKCA—melanoma	9.63e-06	2.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ERCC2—melanoma	9.55e-06	2.69e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP17A1—melanoma	9.08e-06	2.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNA11—melanoma	8.57e-06	2.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FASN—melanoma	8.39e-06	2.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC5A5—melanoma	8.25e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNAQ—melanoma	7.97e-06	2.24e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CD44—melanoma	7.97e-06	2.24e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.91e-06	2.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1B1—melanoma	7.64e-06	2.15e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CG—melanoma	7.54e-06	2.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—melanoma	7.28e-06	2.05e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CD—melanoma	6.63e-06	1.87e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—melanoma	6.55e-06	1.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—melanoma	6.29e-06	1.77e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PRKCA—melanoma	5.79e-06	1.63e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CB—melanoma	5.78e-06	1.63e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ERCC2—melanoma	5.74e-06	1.62e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—melanoma	5.73e-06	1.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTEN—melanoma	4.99e-06	1.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CG—melanoma	4.54e-06	1.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—melanoma	4.38e-06	1.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CD—melanoma	3.99e-06	1.12e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—melanoma	3.94e-06	1.11e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—melanoma	3.52e-06	9.92e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CB—melanoma	3.48e-06	9.78e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—melanoma	3.44e-06	9.7e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTEN—melanoma	3e-06	8.45e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—melanoma	2.88e-06	8.1e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—melanoma	2.12e-06	5.96e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—melanoma	1.73e-06	4.87e-06	CbGpPWpGaD
